Home
Storia in 1 fonti
GLP-1s may nearly halve risk for hepatic complications in MASLD, type 2 diabetes
Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes, according to data.The observational study, published in The American Journal of Gastroenterology, showed that the reduction was prompted by fewer cases of incident cirrhosis. Researchers also found that GLP-1s may
Raccontata da
healio.com
Timeline cronologica
- ·
GLP-1s may nearly halve risk for hepatic complications in MASLD, type 2 diabetes
Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic dysfunction-associated steatotic liver disease and type 2…
- ·
GLP-1 use tied to lower heart, thrombotic risk in adults with obesity, autoimmune disease
NEW ORLEANS — Individuals with obesity and autoimmune diseases who use a GLP-1 receptor agonist may have lower risk for mortality, fewer cardiovascular and thrombotic events and…
- ·
Migraines do not improve, but health care utilization decreases following GLP-1 initiation
Patients with migraine who began using GLP-1 receptor agonists for obesity did not experience any significant changes in headache outcomes, according to data presented at the…